➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Merck
Boehringer Ingelheim
McKesson
Johnson and Johnson

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FLIBANSERIN

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Flibanserin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00277914 ↗ Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women Completed Sprout Pharmaceuticals, Inc Phase 3 2006-01-01 To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment.
NCT00360243 ↗ 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA Completed Sprout Pharmaceuticals, Inc Phase 3 2006-07-01 This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meet standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.
NCT00360529 ↗ 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder Completed Sprout Pharmaceuticals, Inc Phase 3 2006-07-01 This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.
NCT00360555 ↗ Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder Completed Sprout Pharmaceuticals, Inc Phase 3 2006-07-01 This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard diagnostic criteria. Efficacy for flibanserin will be assessed vs. a parallel placebo group.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Flibanserin

Condition Name

Condition Name for Flibanserin
Intervention Trials
Sexual Dysfunctions, Psychological 13
Hypoactive Sexual Desire Disorder 2
Healthy 2
Depression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Flibanserin
Intervention Trials
Sexual Dysfunctions, Psychological 16
Hypokinesia 2
Adenocarcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Flibanserin

Trials by Country

Trials by Country for Flibanserin
Location Trials
United States 310
Canada 44
Germany 3
Finland 2
Hungary 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Flibanserin
Location Trials
Illinois 11
Tennessee 11
Florida 11
California 11
Texas 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Flibanserin

Clinical Trial Phase

Clinical Trial Phase for Flibanserin
Clinical Trial Phase Trials
Phase 4 1
Phase 3 12
Phase 2 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Flibanserin
Clinical Trial Phase Trials
Completed 11
Terminated 4
Not yet recruiting 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Flibanserin

Sponsor Name

Sponsor Name for Flibanserin
Sponsor Trials
Sprout Pharmaceuticals, Inc 14
University of Chicago 1
San Diego Sexual Medicine 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Flibanserin
Sponsor Trials
Industry 16
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKinsey
Baxter
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.